Subhashis Banerjee's most recent trade in Artiva Biotherapeutics Inc was a trade of 7,037 Common Stock done at an average price of $9.0 . Disclosure was reported to the exchange on May 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 7,037 | 144,963 | - | 9.0 | 63,386 | Common Stock |
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 102,000 | 152,000 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 50,000 | 50,000 | - | 0 | Common Stock |